Resource

Learn more by watching our webinar

The number of monoclonal antibody (mAb) drugs making it to market will continue to rise, due to the increase seen in FDA approvals of mAb drugs with specific therapeutic indications. To accelerate the delivery of life-saving therapeutics, it is essential to evaluate ways to help maximize production efficiencies, while minimizing risk, to stay up to speed with the growing demand. Watch the webinar to learn more about accelerating mAb drug development to meet increase in recent mAb FDA approvals.

Learning Objectives

Common challenges and obstacles
Optimizing development processes
Reducing time to market
Selecting the right partner

Speakers:

Scott J. Jacobia, Ph.D.
Director, R&D, Gibco PD-Express™ Services
Thermo Fisher Scientific
Biography ›

Sonjoy Mukerjee, Ph.D.
Principal Application Scientist, Cell Culture, BioProduction
Thermo Fisher Scientific
Biography ›

(*Indicates a mandatory field)

First Name*

Last Name*

Institution*

Telephone*

Email*

City*

Country/Region*

Thermo Fisher is here to help you succeed in taking your discovery to commercial realization. Would you like to have a technical expert contact you to learn more about our offerings in any one of these categories?

Gibco Cell Culture Solutions

Single-Use Technologies

Chromatography and Protein Purification Products

Process Analytics

cGMP Chemical Sourcing

Process Liquid and Buffer Manufacturing